e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Aetiology and treatment of community-acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of influenza vaccination in patients with CAP
A. Tessmer, T. Welte, R. Schmidt-Ott, S. Eberle, N. Suttorp, R. Marre, T. Schaberg (Berlin, Hannover, Munich, Ulm, Rotenburg, Germany)
Source:
Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Session:
Aetiology and treatment of community-acquired pneumonia
Session type:
E-Communication Session
Number:
3194
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Tessmer, T. Welte, R. Schmidt-Ott, S. Eberle, N. Suttorp, R. Marre, T. Schaberg (Berlin, Hannover, Munich, Ulm, Rotenburg, Germany). Impact of influenza vaccination in patients with CAP. Eur Respir J 2009; 34: Suppl. 53, 3194
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Efficacy of influenza and pneumococcal vaccinations among patients with COPD
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007
Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
Outcome of influenza vaccination in elderly with pneumonia
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Influenza and pneumococcal vaccination in patients with COPD
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
Source: Eur Respir J 2004; 23: 363-368
Year: 2004
Cytokine response in pediatric patients with pandemic H1N1 influenza virus infection and pneumonia: Comparison with pediatric pneumonia without H1N1 infection
Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection
Year: 2011
Influenza vaccination in COPD
Source: International Congress 2019 – Vaccines against respiratory infections
Year: 2019
Vaccination rates against pneumococcal and influenza infection in hospitalized cardiologic and pneumologic patients need to be improved.
Source: International Congress 2018 – Respiratory epidemiology: from infectious diseases to lung cancer
Year: 2018
Influenza vaccination and its relation with LRTI
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009
Antibody response to influenza vaccine in patients with sarcoidosis
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010
Characteristics and outcome of pneumonia in patients with 2009 pandemic influenza A/H1N1.
Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis
Year: 2010
Seasonal influenza vaccination rates in chronic asthma patients
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012
Influenza A/H1N1 vaccination in lung a transplant program: Coverage, safety and clinical effectiveness during the pandemic 2009/2010
Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Year: 2010
Pneumococcal and influenza vaccination
Source: Eur Respir Monogr 2014; 63: 266-284
Year: 2014
Characteristics of patients diagnosed of influenza A virus (H1N1) infection in relation to service in charge
Source: Annual Congress 2010 - Influenza A (H1N1): epidemiology
Year: 2010
Evaluation of pneumonia cases due to pandemic influenza A (H1N1)
Source: Annual Congress 2010 - Influenza A (H1N1): epidemiology
Year: 2010
Compliance with the pneumococcal and influenza vaccination recommendations in patients with COPD in Catalonia (Spain)
Source: Eur Respir J 2005; 26: Suppl. 49, 594s
Year: 2005
Early diagnosis and causal treatment of pneumonia associated with pandemic influenza A (H1N1) virus
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept